よむ、つかう、まなぶ。
【資料２】薬剤耐性ワンヘルス動向調査年次報告書2024（たたき台） (119 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_47987.html |
| 出典情報 | 薬剤耐性ワンヘルス動向調査検討会（第12回 1／8）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
Infect. Microbiol. 13, 1168451 (2023).
4.
Khalifa, H. O. et al. First Report of Foodborne Klebsiella pneumoniae Coharboring blaVIM-1, blaNDM-1, and mcr-9. Antimicrob
Agents Chemocher. 64, (2020).
5.
Gomi, R. et al. Emergence of rare carbapenemases (FRI, GES-5, IMI, SFC and SFH-1) in Enterobacterales isolated from
surface waters in Japan. J. Antimicrob. Chemother. 77, 1237–1246 (2022).
6.
日本医療研究開発機構(AMED) 新興・再興感染症に対する革新的医薬品等開発推進研究事業、課題番号 JP22fk0108132、
研究開発課題名：WHO サーベイランスと協調したワンヘルス薬剤耐性菌動向調査に係る研究、研究開発代表者：菅井 基行、
所属研究機関：国立感染症研究所、研究開発期間：令和 2 年 4 月 1 日~令和 5 年 3 月 31 日.
7.
Mahamat, O. O. et al. Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in hospital and
community settings in Chad. Antimicrob. Resist. Infect. Control 8, 169 (2019).
8.
Kurz, M. S. E. et al. Intense pre‐admission carriage and further acquisition of ESBL-producing Enterobacteriaceae
among patients and their caregivers in a tertiary hospital in Rwanda. Trop. Med. Int. Heal. 22, 210–220 (2017).
9.
Karanika, S., Karantanos, T., Arvanitis, M., Grigoras, C. & Mylonakis, E. Fecal Colonization with Extended-spectrum Betalactamase–Producing Enterobacteriaceae and Risk Factors Among Healthy Individuals: A Systematic Review and
Metaanalysis. Clin. Infect. Dis. 63, 310–318 (2016).
10. Rettedal, S. et al. Extended-spectrum β-lactamase-producing Enterobacteriaceae among pregnant women in Norway:
prevalence and maternal–neonatal transmission. J. Perinatol. 35, 907–912 (2015).
11. Sintondji, K. et al. Prevalence and characterization of ESBL-producing Escherichia coli in healthy pregnant women and
hospital environments in Benin: an approach based on Tricycle. Front. Public Heal. 11, 1227000 (2023).
12. Ghaddar, N. et al. Phenotypic and Genotypic Characterization of Extended-Spectrum Beta-Lactamases Produced by
Escherichia coli Colonizing Pregnant Women. Infect. Dis. Obstet. Gynecol. 2020, 4190306 (2020).
13. Chereau, F. et al. Colonization of Extended-Spectrum-β-Lactamase- and NDM-1-Producing Enterobacteriaceae among
Pregnant Women in the Community in a Low-Income Country: a Potential Reservoir for Transmission of Multiresistant
Enterobacteriaceae to Neonates. Antimicrob. Agents Chemother. 59, 3652–3655 (2015).
14. Bezabih, Y. M. et al. Comparison of the global prevalence and trend of human intestinal carriage of ESBL-producing
Escherichia coli between healthcare and community settings: a systematic review and meta-analysis. JAC-Antimicrob.
Resist. 4, dlac048 (2022).
15. 薬剤耐性ワンヘルス動向調査年次報告書 2023 (https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000120172.html).
16. Banu, R. A. et al. Extended Spectrum Beta-Lactamase Escherichia coli in River Waters Collected from Two Cities in Ghana,
2018–2020. Trop. Med. Infect. Dis. 6, 105 (2021).
17. Puspandari, N. et al. Extended spectrum beta-lactamase-producing Escherichia coli surveillance in the human, food chain,
and environment sectors: Tricycle project (pilot) in Indonesia. One Heal 13, 100331 (2021).
18. Appling, K. C., Sobsey, M. D., Durso, L. M. & Fisher, M. B. Environmental monitoring of antimicrobial resistant bacteria in
North Carolina water and wastewater using the WHO Tricycle protocol in combination with membrane filtration and
compartment bag test methods for detecting and quantifying ESBL E. coli. PLOS Water 2, e0000117 (2023).
114
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
Infect. Microbiol. 13, 1168451 (2023).
4.
Khalifa, H. O. et al. First Report of Foodborne Klebsiella pneumoniae Coharboring blaVIM-1, blaNDM-1, and mcr-9. Antimicrob
Agents Chemocher. 64, (2020).
5.
Gomi, R. et al. Emergence of rare carbapenemases (FRI, GES-5, IMI, SFC and SFH-1) in Enterobacterales isolated from
surface waters in Japan. J. Antimicrob. Chemother. 77, 1237–1246 (2022).
6.
日本医療研究開発機構(AMED) 新興・再興感染症に対する革新的医薬品等開発推進研究事業、課題番号 JP22fk0108132、
研究開発課題名：WHO サーベイランスと協調したワンヘルス薬剤耐性菌動向調査に係る研究、研究開発代表者：菅井 基行、
所属研究機関：国立感染症研究所、研究開発期間：令和 2 年 4 月 1 日~令和 5 年 3 月 31 日.
7.
Mahamat, O. O. et al. Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in hospital and
community settings in Chad. Antimicrob. Resist. Infect. Control 8, 169 (2019).
8.
Kurz, M. S. E. et al. Intense pre‐admission carriage and further acquisition of ESBL-producing Enterobacteriaceae
among patients and their caregivers in a tertiary hospital in Rwanda. Trop. Med. Int. Heal. 22, 210–220 (2017).
9.
Karanika, S., Karantanos, T., Arvanitis, M., Grigoras, C. & Mylonakis, E. Fecal Colonization with Extended-spectrum Betalactamase–Producing Enterobacteriaceae and Risk Factors Among Healthy Individuals: A Systematic Review and
Metaanalysis. Clin. Infect. Dis. 63, 310–318 (2016).
10. Rettedal, S. et al. Extended-spectrum β-lactamase-producing Enterobacteriaceae among pregnant women in Norway:
prevalence and maternal–neonatal transmission. J. Perinatol. 35, 907–912 (2015).
11. Sintondji, K. et al. Prevalence and characterization of ESBL-producing Escherichia coli in healthy pregnant women and
hospital environments in Benin: an approach based on Tricycle. Front. Public Heal. 11, 1227000 (2023).
12. Ghaddar, N. et al. Phenotypic and Genotypic Characterization of Extended-Spectrum Beta-Lactamases Produced by
Escherichia coli Colonizing Pregnant Women. Infect. Dis. Obstet. Gynecol. 2020, 4190306 (2020).
13. Chereau, F. et al. Colonization of Extended-Spectrum-β-Lactamase- and NDM-1-Producing Enterobacteriaceae among
Pregnant Women in the Community in a Low-Income Country: a Potential Reservoir for Transmission of Multiresistant
Enterobacteriaceae to Neonates. Antimicrob. Agents Chemother. 59, 3652–3655 (2015).
14. Bezabih, Y. M. et al. Comparison of the global prevalence and trend of human intestinal carriage of ESBL-producing
Escherichia coli between healthcare and community settings: a systematic review and meta-analysis. JAC-Antimicrob.
Resist. 4, dlac048 (2022).
15. 薬剤耐性ワンヘルス動向調査年次報告書 2023 (https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000120172.html).
16. Banu, R. A. et al. Extended Spectrum Beta-Lactamase Escherichia coli in River Waters Collected from Two Cities in Ghana,
2018–2020. Trop. Med. Infect. Dis. 6, 105 (2021).
17. Puspandari, N. et al. Extended spectrum beta-lactamase-producing Escherichia coli surveillance in the human, food chain,
and environment sectors: Tricycle project (pilot) in Indonesia. One Heal 13, 100331 (2021).
18. Appling, K. C., Sobsey, M. D., Durso, L. M. & Fisher, M. B. Environmental monitoring of antimicrobial resistant bacteria in
North Carolina water and wastewater using the WHO Tricycle protocol in combination with membrane filtration and
compartment bag test methods for detecting and quantifying ESBL E. coli. PLOS Water 2, e0000117 (2023).
114